Edition:
United Kingdom

PTC Inc (PTC.OQ)

PTC.OQ on NASDAQ Stock Exchange Global Select Market

85.02USD
14 Dec 2018
Change (% chg)

$-1.76 (-2.03%)
Prev Close
$86.78
Open
$85.20
Day's High
$87.00
Day's Low
$84.50
Volume
429,564
Avg. Vol
533,665
52-wk High
$107.39
52-wk Low
$59.40

Chart for

About

PTC Inc. is a global computer software and services company. The Company offers a portfolio of computer-aided design (CAD) modeling, product lifecycle management (PLM) and service lifecycle management (SLM) solutions for manufacturers to create, operate, and service products. It offers a suite of Internet of Things (IoT)... (more)

Overall

Beta: 1.33
Market Cap(Mil.): $6,742.23
Shares Outstanding(Mil.): 115.61
Dividend: --
Yield (%): --

Financials

  PTC.OQ Industry Sector
P/E (TTM): -- 34.47 1,220.99
EPS (TTM): -0.34 -- --
ROI: -2.35 14.14 14.01
ROE: -4.67 15.39 14.16

Roche SMA drug shines in study as costly new therapies advance

ZURICH A drug being co-developed by Roche to treat spinal muscular atrophy (SMA) helped improve development scores in babies with the genetic disease, a study released on Monday showed, as the race heats up for therapies destined to be among the drug industry's most expensive.

18 Jun 2018

Roche SMA drug shines in study as costly new therapies advance

ZURICH, June 18 A drug being co-developed by Roche to treat spinal muscular atrophy (SMA) helped improve development scores in babies with the genetic disease, a study released on Monday showed, as the race heats up for therapies destined to be among the drug industry's most expensive.

18 Jun 2018

Earnings vs. Estimates